Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Diosgenin is a **natural steroidal sapogenin** phytochemical found primarily in yams (*Dioscorea* species) and some other plants. It is **used as a starting material for the commercial synthesis of steroid hormones** such as cortisone, pregnenolone, and progesterone[7][3][1]. Diosgenin exhibits a wide range of **biological activities** in preclinical studies, including anti-cancer, anti-inflammatory, anti-thrombotic, anti-hyperlipidemic, immunomodulatory, antioxidant, and anti-diabetic effects[3][1]. It has been used as a research tool for the investigation of mechanisms in cancer, cardiovascular disease, diabetes, neuroprotection, osteoporosis, and skin disorders[3][1]. While multiple preclinical and some early clinical studies show promise and report diosgenin's **non-toxic nature and diverse pharmacological actions**, there is no established pharmaceutical application for diosgenin itself as a therapeutic; rather, it is crucial as a precursor for the industrial synthesis of steroid drugs[1][7][3]. Its mechanisms of action are suggested to involve **inhibition of cancer cell proliferation, induction of apoptosis, anti-inflammatory pathways, and modulation of immune responses**[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on diosgenin.